| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
117,691 |
99,955 |
$10.20M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,062 |
16,058 |
$2.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,086 |
10,249 |
$2.17M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,886 |
13,385 |
$1.57M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,427 |
2,155 |
$287K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,490 |
2,425 |
$249K |
| 36415 |
Collection of venous blood by venipuncture |
33,621 |
29,213 |
$225K |
| 80053 |
Comprehensive metabolic panel |
12,208 |
11,073 |
$120K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,328 |
1,210 |
$106K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,755 |
2,695 |
$105K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,822 |
1,230 |
$86K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
422 |
386 |
$68K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,819 |
2,331 |
$56K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
555 |
149 |
$48K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,194 |
1,116 |
$46K |
| 73630 |
|
950 |
766 |
$43K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,775 |
1,449 |
$42K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,025 |
892 |
$41K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,218 |
11,056 |
$37K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,070 |
1,005 |
$35K |
| 87631 |
|
372 |
342 |
$35K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
276 |
92 |
$28K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
235 |
228 |
$28K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
622 |
293 |
$26K |
| 70450 |
Computed tomography, head or brain; without contrast material |
178 |
156 |
$22K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
183 |
181 |
$21K |
| 71045 |
Radiologic examination, chest; single view |
532 |
474 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
408 |
390 |
$19K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,054 |
1,797 |
$18K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,705 |
1,466 |
$16K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
119 |
65 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
495 |
371 |
$14K |
| 0002A |
|
456 |
428 |
$13K |
| 0001A |
|
450 |
431 |
$13K |
| 0240U |
|
81 |
78 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
488 |
400 |
$11K |
| 90834 |
Psychotherapy, 45 minutes with patient |
117 |
78 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
411 |
380 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
210 |
144 |
$8K |
| 81001 |
|
2,135 |
1,969 |
$7K |
| 84484 |
|
1,375 |
983 |
$7K |
| 90686 |
|
444 |
412 |
$5K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
56 |
52 |
$5K |
| 90791 |
Psychiatric diagnostic evaluation |
26 |
26 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,197 |
1,616 |
$5K |
| 83605 |
|
1,275 |
1,062 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18 |
12 |
$5K |
| 83735 |
|
2,391 |
2,172 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
439 |
393 |
$4K |
| 82746 |
|
399 |
369 |
$4K |
| 82728 |
|
411 |
380 |
$4K |
| 85027 |
|
1,563 |
1,401 |
$4K |
| 69210 |
|
84 |
84 |
$4K |
| 86140 |
|
981 |
877 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
27 |
25 |
$3K |
| 96130 |
|
14 |
12 |
$3K |
| 82607 |
|
398 |
368 |
$3K |
| 0072A |
|
84 |
73 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
342 |
310 |
$3K |
| 0071A |
|
85 |
71 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
132 |
128 |
$2K |
| 87480 |
|
212 |
191 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,245 |
1,061 |
$2K |
| 84703 |
|
881 |
799 |
$2K |
| 0004A |
|
109 |
91 |
$2K |
| 87634 |
|
82 |
78 |
$2K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
30 |
29 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
362 |
337 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
27 |
24 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
84 |
81 |
$2K |
| 84481 |
|
267 |
253 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
45 |
25 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
365 |
351 |
$1K |
| 90785 |
|
13 |
12 |
$1K |
| 87510 |
|
212 |
191 |
$1K |
| 0064A |
|
77 |
69 |
$1K |
| 76830 |
Ultrasound, transvaginal |
13 |
12 |
$1K |
| 84439 |
|
297 |
281 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
69 |
64 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
771 |
711 |
$1K |
| 82553 |
|
161 |
130 |
$1K |
| 86850 |
|
92 |
89 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
103 |
99 |
$977.24 |
| J2704 |
Injection, propofol, 10 mg |
492 |
434 |
$972.38 |
| 80061 |
Lipid panel |
92 |
85 |
$929.46 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
561 |
449 |
$890.43 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
69 |
64 |
$882.18 |
| 82077 |
|
445 |
390 |
$874.21 |
| 87660 |
|
212 |
191 |
$873.87 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
124 |
121 |
$808.86 |
| 84425 |
|
114 |
112 |
$752.81 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
149 |
131 |
$681.84 |
| 0052A |
|
19 |
19 |
$654.81 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
319 |
264 |
$600.53 |
| 83655 |
|
43 |
42 |
$599.96 |
| 90662 |
|
38 |
32 |
$557.53 |
| 82550 |
|
195 |
157 |
$556.70 |
| 0054A |
|
18 |
18 |
$555.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
275 |
267 |
$547.90 |
| 0031A |
|
25 |
24 |
$535.26 |
| 86900 |
|
52 |
51 |
$534.44 |
| 85610 |
|
359 |
302 |
$521.92 |
| 85730 |
|
196 |
164 |
$449.24 |
| 81003 |
|
530 |
486 |
$433.31 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
159 |
127 |
$426.20 |
| 0051A |
|
12 |
12 |
$426.09 |
| 88142 |
|
58 |
51 |
$400.93 |
| 0012A |
|
20 |
20 |
$338.75 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
244 |
220 |
$299.01 |
| 98940 |
|
20 |
13 |
$282.18 |
| 86901 |
|
52 |
51 |
$280.48 |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
17 |
13 |
$264.13 |
| 83690 |
|
169 |
148 |
$225.69 |
| 0011A |
|
18 |
18 |
$218.79 |
| 87081 |
|
160 |
159 |
$206.09 |
| J3360 |
Injection, diazepam, up to 5 mg |
14 |
12 |
$164.15 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
14 |
13 |
$147.96 |
| 82962 |
|
228 |
197 |
$147.15 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
117 |
107 |
$140.08 |
| 36416 |
|
100 |
88 |
$111.85 |
| 87040 |
|
44 |
26 |
$105.10 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
41 |
41 |
$85.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
13 |
12 |
$39.82 |
| 85652 |
|
13 |
13 |
$35.33 |
| 80179 |
|
37 |
37 |
$27.51 |
| 80143 |
|
37 |
37 |
$27.51 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
18 |
15 |
$22.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
15 |
$4.50 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17 |
16 |
$2.59 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
122 |
59 |
$0.00 |
| 84100 |
|
46 |
39 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
15 |
14 |
$0.00 |
| 96127 |
|
15 |
14 |
$0.00 |
| 83880 |
|
15 |
13 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
14 |
13 |
$0.00 |